位置:首页 > 蛋白库 > FABH_ECOLI
FABH_ECOLI
ID   FABH_ECOLI              Reviewed;         317 AA.
AC   P0A6R0; P24249;
DT   10-MAY-2005, integrated into UniProtKB/Swiss-Prot.
DT   10-MAY-2005, sequence version 1.
DT   03-AUG-2022, entry version 143.
DE   RecName: Full=3-oxoacyl-[acyl-carrier-protein] synthase 3 {ECO:0000255|HAMAP-Rule:MF_01815};
DE            EC=2.3.1.180 {ECO:0000255|HAMAP-Rule:MF_01815, ECO:0000269|PubMed:10629181, ECO:0000269|PubMed:7592873, ECO:0000269|PubMed:8631920, ECO:0000269|PubMed:8910376};
DE   AltName: Full=3-oxoacyl-[acyl-carrier-protein] synthase III {ECO:0000255|HAMAP-Rule:MF_01815};
DE   AltName: Full=Beta-ketoacyl-ACP synthase III {ECO:0000255|HAMAP-Rule:MF_01815};
DE            Short=KAS III {ECO:0000255|HAMAP-Rule:MF_01815};
DE   AltName: Full=EcFabH;
GN   Name=fabH; OrderedLocusNames=b1091, JW1077;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND PROTEIN SEQUENCE OF 1-30.
RC   STRAIN=K12;
RX   PubMed=1551888; DOI=10.1016/s0021-9258(19)50498-7;
RA   Tsay J.-T., Oh W., Larson T.J., Jackowski S., Rock C.O.;
RT   "Isolation and characterization of the beta-ketoacyl-acyl carrier protein
RT   synthase III gene (fabH) from Escherichia coli K-12.";
RL   J. Biol. Chem. 267:6807-6814(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J., Mau B.,
RA   Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains MG1655
RT   and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-76.
RC   STRAIN=K12;
RX   PubMed=1447160; DOI=10.1128/jb.174.23.7873-7874.1992;
RA   Oh W., Larson T.J.;
RT   "Physical locations of genes in the rne (ams)-rpmF-plsX-fab region of the
RT   Escherichia coli K-12 chromosome.";
RL   J. Bacteriol. 174:7873-7874(1992).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 147-317.
RX   PubMed=1314802; DOI=10.1128/jb.174.9.2851-2857.1992;
RA   Verwoert I.I.G.S., Verbree E.C., van der Linden K.H., Nijkamp H.J.,
RA   Stuitje A.R.;
RT   "Cloning, nucleotide sequence, and expression of the Escherichia coli fabD
RT   gene, encoding malonyl coenzyme A-acyl carrier protein transacylase.";
RL   J. Bacteriol. 174:2851-2857(1992).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 201-317.
RC   STRAIN=K12;
RX   PubMed=1339356; DOI=10.1016/0014-5793(92)80128-4;
RA   Magnuson K., Oh W., Larson T.J., Cronan J.E. Jr.;
RT   "Cloning and nucleotide sequence of the fabD gene encoding malonyl coenzyme
RT   A-acyl carrier protein transacylase of Escherichia coli.";
RL   FEBS Lett. 299:262-266(1992).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 201-317.
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=8905232; DOI=10.1093/dnares/3.3.137;
RA   Oshima T., Aiba H., Baba T., Fujita K., Hayashi K., Honjo A., Ikemoto K.,
RA   Inada T., Itoh T., Kajihara M., Kanai K., Kashimoto K., Kimura S.,
RA   Kitagawa M., Makino K., Masuda S., Miki T., Mizobuchi K., Mori H.,
RA   Motomura K., Nakamura Y., Nashimoto H., Nishio Y., Saito N., Sampei G.,
RA   Seki Y., Tagami H., Takemoto K., Wada C., Yamamoto Y., Yano M.,
RA   Horiuchi T.;
RT   "A 718-kb DNA sequence of the Escherichia coli K-12 genome corresponding to
RT   the 12.7-28.0 min region on the linkage map.";
RL   DNA Res. 3:137-155(1996).
RN   [8]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=7592873; DOI=10.1074/jbc.270.44.26538;
RA   Heath R.J., Rock C.O.;
RT   "Enoyl-acyl carrier protein reductase (fabI) plays a determinant role in
RT   completing cycles of fatty acid elongation in Escherichia coli.";
RL   J. Biol. Chem. 270:26538-26542(1995).
RN   [9]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND ACTIVITY
RP   REGULATION.
RX   PubMed=8631920; DOI=10.1074/jbc.271.18.10996;
RA   Heath R.J., Rock C.O.;
RT   "Inhibition of beta-ketoacyl-acyl carrier protein synthase III (FabH) by
RT   acyl-acyl carrier protein in Escherichia coli.";
RL   J. Biol. Chem. 271:10996-11000(1996).
RN   [10]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=8910376; DOI=10.1074/jbc.271.44.27795;
RA   Heath R.J., Rock C.O.;
RT   "Roles of the FabA and FabZ beta-hydroxyacyl-acyl carrier protein
RT   dehydratases in Escherichia coli fatty acid biosynthesis.";
RL   J. Biol. Chem. 271:27795-27801(1996).
RN   [11]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=10629181; DOI=10.1128/jb.182.2.365-370.2000;
RA   Choi K.-H., Heath R.J., Rock C.O.;
RT   "Beta-ketoacyl-acyl carrier protein synthase III (FabH) is a determining
RT   factor in branched-chain fatty acid biosynthesis.";
RL   J. Bacteriol. 182:365-370(2000).
RN   [12]
RP   DOMAIN, AND MUTAGENESIS OF LYS-214; ARG-249; ALA-253 AND 256-LYS-LYS-257.
RX   PubMed=11078736; DOI=10.1074/jbc.m008042200;
RA   Zhang Y.-M., Rao M.S., Heath R.J., Price A.C., Olson A.J., Rock C.O.,
RA   White S.W.;
RT   "Identification and analysis of the acyl carrier protein (ACP) docking site
RT   on beta-ketoacyl-ACP synthase III.";
RL   J. Biol. Chem. 276:8231-8238(2001).
RN   [13]
RP   INHIBITION BY ANTIBIOTICS.
RX   PubMed=11375394; DOI=10.1074/jbc.m101769200;
RA   Khandekar S.S., Gentry D.R., Van Aller G.S., Warren P., Xiang H.,
RA   Silverman C., Doyle M.L., Chambers P.A., Konstantinidis A.K., Brandt M.,
RA   Daines R.A., Lonsdale J.T.;
RT   "Identification, substrate specificity, and inhibition of the Streptococcus
RT   pneumoniae beta-ketoacyl-acyl carrier protein synthase III (FabH).";
RL   J. Biol. Chem. 276:30024-30030(2001).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS), AND ACTIVE SITE.
RX   PubMed=10593943; DOI=10.1074/jbc.274.51.36465;
RA   Qiu X., Janson C.A., Konstantinidis A.K., Nwagwu S., Silverman C.,
RA   Smith W.W., Khandekar S., Lonsdale J., Abdel-Meguid S.S.;
RT   "Crystal structure of beta-ketoacyl-acyl carrier protein synthase III. A
RT   key condensing enzyme in bacterial fatty acid biosynthesis.";
RL   J. Biol. Chem. 274:36465-36471(1999).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS), AND ACTIVE SITE.
RX   PubMed=10673437; DOI=10.1016/s0969-2126(00)00094-0;
RA   Davies C., Heath R.J., White S.W., Rock C.O.;
RT   "The 1.8-A crystal structure and active-site architecture of beta-ketoacyl-
RT   acyl carrier protein synthase III (FabH) from Escherichia coli.";
RL   Structure 8:185-195(2000).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS), AND ACTIVE SITE.
RX   PubMed=11243824; DOI=10.1006/jmbi.2000.4457;
RA   Qiu X., Janson C.A., Smith W.W., Head M., Lonsdale J., Konstantinidis A.K.;
RT   "Refined structures of beta-ketoacyl-acyl carrier protein synthase III.";
RL   J. Mol. Biol. 307:341-356(2001).
CC   -!- FUNCTION: Catalyzes the condensation reaction of fatty acid synthesis
CC       by the addition to an acyl acceptor of two carbons from malonyl-ACP.
CC       Catalyzes the first condensation reaction which initiates fatty acid
CC       synthesis and may therefore play a role in governing the total rate of
CC       fatty acid production. Possesses both acetoacetyl-ACP synthase and
CC       acetyl transacylase activities. Has some substrate specificity for
CC       acetyl-CoA. Its substrate specificity determines the biosynthesis of
CC       straight-chain of fatty acids instead of branched-chain
CC       (PubMed:7592873, PubMed:8631920, PubMed:8910376, PubMed:10629181). Can
CC       also use propionyl-CoA, with lower efficiency (PubMed:8631920,
CC       PubMed:10629181). {ECO:0000269|PubMed:10629181,
CC       ECO:0000269|PubMed:7592873, ECO:0000269|PubMed:8631920,
CC       ECO:0000269|PubMed:8910376}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=acetyl-CoA + H(+) + malonyl-[ACP] = 3-oxobutanoyl-[ACP] + CO2
CC         + CoA; Xref=Rhea:RHEA:12080, Rhea:RHEA-COMP:9623, Rhea:RHEA-
CC         COMP:9625, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57288, ChEBI:CHEBI:78449, ChEBI:CHEBI:78450;
CC         EC=2.3.1.180; Evidence={ECO:0000255|HAMAP-Rule:MF_01815,
CC         ECO:0000269|PubMed:10629181, ECO:0000269|PubMed:7592873,
CC         ECO:0000269|PubMed:8631920, ECO:0000269|PubMed:8910376};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:12081;
CC         Evidence={ECO:0000269|PubMed:10629181, ECO:0000269|PubMed:7592873,
CC         ECO:0000269|PubMed:8631920, ECO:0000269|PubMed:8910376};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + malonyl-[ACP] + propanoyl-CoA = 3-oxopentanoyl-[ACP] +
CC         CO2 + CoA; Xref=Rhea:RHEA:42244, Rhea:RHEA-COMP:9623, Rhea:RHEA-
CC         COMP:9939, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57392, ChEBI:CHEBI:78449, ChEBI:CHEBI:78818;
CC         Evidence={ECO:0000269|PubMed:10629181, ECO:0000269|PubMed:8631920};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:42245;
CC         Evidence={ECO:0000269|PubMed:10629181, ECO:0000269|PubMed:8631920};
CC   -!- ACTIVITY REGULATION: Negatively regulated by acyl-ACP, possibly by
CC       binding to either the free enzyme or the acyl-enzyme intermediate.
CC       {ECO:0000269|PubMed:8631920}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=40 uM for acetyl-CoA {ECO:0000269|PubMed:8631920};
CC         KM=5 uM for malonyl-[ACP] {ECO:0000269|PubMed:8631920};
CC   -!- PATHWAY: Lipid metabolism; fatty acid biosynthesis. {ECO:0000255|HAMAP-
CC       Rule:MF_01815}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000255|HAMAP-Rule:MF_01815}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_01815}.
CC   -!- DOMAIN: The last Arg residue of the ACP-binding site is essential for
CC       the weak association between ACP/AcpP and FabH. {ECO:0000255|HAMAP-
CC       Rule:MF_01815, ECO:0000269|PubMed:11078736}.
CC   -!- MISCELLANEOUS: Inhibited by the SB418011 antibiotic. Not inhibited by
CC       cerulenin and thiolactomycin.
CC   -!- SIMILARITY: Belongs to the thiolase-like superfamily. FabH family.
CC       {ECO:0000255|HAMAP-Rule:MF_01815, ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M77744; AAA23749.1; -; Genomic_DNA.
DR   EMBL; M96793; AAB59065.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC74175.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAA35899.2; -; Genomic_DNA.
DR   EMBL; M87040; AAA23741.1; -; Genomic_DNA.
DR   EMBL; Z11565; CAA77659.1; -; Genomic_DNA.
DR   PIR; A42431; A42431.
DR   RefSeq; NP_415609.1; NC_000913.3.
DR   RefSeq; WP_000288132.1; NZ_STEB01000016.1.
DR   PDB; 1EBL; X-ray; 1.80 A; A/B=1-317.
DR   PDB; 1HN9; X-ray; 2.00 A; A/B=1-317.
DR   PDB; 1HND; X-ray; 1.60 A; A=1-317.
DR   PDB; 1HNH; X-ray; 1.90 A; A=1-317.
DR   PDB; 1HNJ; X-ray; 1.46 A; A=1-317.
DR   PDB; 1HNK; X-ray; 1.90 A; A=1-317.
DR   PDB; 1MZS; X-ray; 2.10 A; A=1-317.
DR   PDB; 2EFT; X-ray; 2.00 A; A/B=1-317.
DR   PDB; 2GYO; X-ray; 2.00 A; A/B=1-317.
DR   PDB; 3IL9; X-ray; 1.85 A; A/B=1-317.
DR   PDB; 4Z8D; X-ray; 2.00 A; A/B=1-317.
DR   PDB; 5BNM; X-ray; 1.70 A; A/B=1-317.
DR   PDB; 5BNR; X-ray; 1.89 A; A=1-317.
DR   PDB; 5BNS; X-ray; 2.20 A; A/B=1-317.
DR   PDB; 6X7R; X-ray; 1.35 A; A=1-317.
DR   PDB; 6X7S; X-ray; 1.35 A; A=1-317.
DR   PDBsum; 1EBL; -.
DR   PDBsum; 1HN9; -.
DR   PDBsum; 1HND; -.
DR   PDBsum; 1HNH; -.
DR   PDBsum; 1HNJ; -.
DR   PDBsum; 1HNK; -.
DR   PDBsum; 1MZS; -.
DR   PDBsum; 2EFT; -.
DR   PDBsum; 2GYO; -.
DR   PDBsum; 3IL9; -.
DR   PDBsum; 4Z8D; -.
DR   PDBsum; 5BNM; -.
DR   PDBsum; 5BNR; -.
DR   PDBsum; 5BNS; -.
DR   PDBsum; 6X7R; -.
DR   PDBsum; 6X7S; -.
DR   AlphaFoldDB; P0A6R0; -.
DR   SMR; P0A6R0; -.
DR   BioGRID; 4261031; 467.
DR   DIP; DIP-48255N; -.
DR   IntAct; P0A6R0; 5.
DR   STRING; 511145.b1091; -.
DR   ChEMBL; CHEMBL4914; -.
DR   DrugBank; DB02316; 1-(5-Carboxypentyl)-5-[(2,6-Dichlorobenzyl)Oxy]-1 H-Indole-2-Carboxylic Acid.
DR   DrugBank; DB01034; Cerulenin.
DR   DrugBank; DB01992; Coenzyme A.
DR   DrugBank; DB03661; L-cysteic acid.
DR   DrugBank; DB04524; Malonyl-CoA.
DR   DrugBank; DB02039; S-Acetyl-Cysteine.
DR   DrugCentral; P0A6R0; -.
DR   SwissLipids; SLP:000000852; -.
DR   CarbonylDB; P0A6R0; -.
DR   jPOST; P0A6R0; -.
DR   PaxDb; P0A6R0; -.
DR   PRIDE; P0A6R0; -.
DR   EnsemblBacteria; AAC74175; AAC74175; b1091.
DR   EnsemblBacteria; BAA35899; BAA35899; BAA35899.
DR   GeneID; 66670643; -.
DR   GeneID; 946003; -.
DR   KEGG; ecj:JW1077; -.
DR   KEGG; eco:b1091; -.
DR   PATRIC; fig|1411691.4.peg.1177; -.
DR   EchoBASE; EB0273; -.
DR   eggNOG; COG0332; Bacteria.
DR   HOGENOM; CLU_039592_4_1_6; -.
DR   InParanoid; P0A6R0; -.
DR   OMA; WGSEGDK; -.
DR   PhylomeDB; P0A6R0; -.
DR   BioCyc; EcoCyc:FABH-MON; -.
DR   BioCyc; MetaCyc:FABH-MON; -.
DR   BRENDA; 2.3.1.180; 2026.
DR   UniPathway; UPA00094; -.
DR   EvolutionaryTrace; P0A6R0; -.
DR   PRO; PR:P0A6R0; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005829; C:cytosol; IDA:EcoCyc.
DR   GO; GO:0004315; F:3-oxoacyl-[acyl-carrier-protein] synthase activity; IEA:InterPro.
DR   GO; GO:0033818; F:beta-ketoacyl-acyl-carrier-protein synthase III activity; IDA:EcoCyc.
DR   GO; GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-UniRule.
DR   GO; GO:0006631; P:fatty acid metabolic process; IMP:CACAO.
DR   Gene3D; 3.40.47.10; -; 1.
DR   HAMAP; MF_01815; FabH; 1.
DR   InterPro; IPR013751; ACP_syn_III.
DR   InterPro; IPR013747; ACP_syn_III_C.
DR   InterPro; IPR004655; FabH_synth.
DR   InterPro; IPR016039; Thiolase-like.
DR   Pfam; PF08545; ACP_syn_III; 1.
DR   Pfam; PF08541; ACP_syn_III_C; 1.
DR   SUPFAM; SSF53901; SSF53901; 1.
DR   TIGRFAMs; TIGR00747; fabH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acyltransferase; Cytoplasm; Direct protein sequencing;
KW   Fatty acid biosynthesis; Fatty acid metabolism; Lipid biosynthesis;
KW   Lipid metabolism; Multifunctional enzyme; Reference proteome; Transferase.
FT   CHAIN           1..317
FT                   /note="3-oxoacyl-[acyl-carrier-protein] synthase 3"
FT                   /id="PRO_0000110424"
FT   REGION          245..249
FT                   /note="ACP-binding"
FT   ACT_SITE        112
FT                   /evidence="ECO:0000305|PubMed:10593943,
FT                   ECO:0000305|PubMed:10673437, ECO:0000305|PubMed:11243824"
FT   ACT_SITE        244
FT                   /evidence="ECO:0000305|PubMed:10593943,
FT                   ECO:0000305|PubMed:10673437, ECO:0000305|PubMed:11243824"
FT   ACT_SITE        274
FT                   /evidence="ECO:0000305|PubMed:10593943,
FT                   ECO:0000305|PubMed:10673437, ECO:0000305|PubMed:11243824"
FT   MUTAGEN         112
FT                   /note="C->S: Loss of activity."
FT   MUTAGEN         214
FT                   /note="K->E,A: Strongly reduces the binding to malonyl-ACP
FT                   but not that of the substrate."
FT                   /evidence="ECO:0000269|PubMed:11078736"
FT   MUTAGEN         244
FT                   /note="H->A: Loss of activity."
FT   MUTAGEN         249
FT                   /note="R->E,A: Abolishes the binding to malonyl-ACP but not
FT                   that of the substrate."
FT                   /evidence="ECO:0000269|PubMed:11078736"
FT   MUTAGEN         253
FT                   /note="A->Y: Abolishes both binding to malonyl-ACP and
FT                   binding to substrate."
FT                   /evidence="ECO:0000269|PubMed:11078736"
FT   MUTAGEN         256..257
FT                   /note="KK->AA: Strongly reduces both binding to malonyl-ACP
FT                   and binding to substrate."
FT                   /evidence="ECO:0000269|PubMed:11078736"
FT   MUTAGEN         256..257
FT                   /note="KK->EE: Abolishes the binding to malonyl-ACP but not
FT                   that of the substrate."
FT                   /evidence="ECO:0000269|PubMed:11078736"
FT   MUTAGEN         274
FT                   /note="N->A: Loss of activity."
FT   STRAND          2..11
FT                   /evidence="ECO:0007829|PDB:6X7R"
FT   STRAND          14..18
FT                   /evidence="ECO:0007829|PDB:6X7R"
FT   HELIX           19..23
FT                   /evidence="ECO:0007829|PDB:6X7R"
FT   HELIX           30..37
FT                   /evidence="ECO:0007829|PDB:6X7R"
FT   STRAND          41..44
FT                   /evidence="ECO:0007829|PDB:6X7R"
FT   HELIX           51..66
FT                   /evidence="ECO:0007829|PDB:6X7R"
FT   HELIX           70..72
FT                   /evidence="ECO:0007829|PDB:6X7R"
FT   STRAND          75..79
FT                   /evidence="ECO:0007829|PDB:6X7R"
FT   STRAND          86..88
FT                   /evidence="ECO:0007829|PDB:6X7R"
FT   HELIX           90..97
FT                   /evidence="ECO:0007829|PDB:6X7R"
FT   STRAND          105..108
FT                   /evidence="ECO:0007829|PDB:6X7R"
FT   HELIX           111..113
FT                   /evidence="ECO:0007829|PDB:6X7R"
FT   HELIX           114..127
FT                   /evidence="ECO:0007829|PDB:6X7R"
FT   STRAND          132..140
FT                   /evidence="ECO:0007829|PDB:6X7R"
FT   HELIX           142..145
FT                   /evidence="ECO:0007829|PDB:6X7R"
FT   HELIX           151..154
FT                   /evidence="ECO:0007829|PDB:6X7R"
FT   STRAND          160..171
FT                   /evidence="ECO:0007829|PDB:6X7R"
FT   STRAND          173..181
FT                   /evidence="ECO:0007829|PDB:6X7R"
FT   HELIX           183..188
FT                   /evidence="ECO:0007829|PDB:6X7R"
FT   STRAND          189..192
FT                   /evidence="ECO:0007829|PDB:1EBL"
FT   STRAND          196..198
FT                   /evidence="ECO:0007829|PDB:6X7R"
FT   STRAND          204..207
FT                   /evidence="ECO:0007829|PDB:4Z8D"
FT   HELIX           209..230
FT                   /evidence="ECO:0007829|PDB:6X7R"
FT   HELIX           235..237
FT                   /evidence="ECO:0007829|PDB:6X7R"
FT   STRAND          240..243
FT                   /evidence="ECO:0007829|PDB:6X7R"
FT   HELIX           248..257
FT                   /evidence="ECO:0007829|PDB:6X7R"
FT   HELIX           262..264
FT                   /evidence="ECO:0007829|PDB:6X7R"
FT   HELIX           269..272
FT                   /evidence="ECO:0007829|PDB:6X7R"
FT   HELIX           276..278
FT                   /evidence="ECO:0007829|PDB:6X7R"
FT   HELIX           279..289
FT                   /evidence="ECO:0007829|PDB:6X7R"
FT   STRAND          298..305
FT                   /evidence="ECO:0007829|PDB:6X7R"
FT   TURN            306..308
FT                   /evidence="ECO:0007829|PDB:6X7R"
FT   STRAND          309..316
FT                   /evidence="ECO:0007829|PDB:6X7R"
SQ   SEQUENCE   317 AA;  33515 MW;  BF3192CFF36023D3 CRC64;
     MYTKIIGTGS YLPEQVRTNA DLEKMVDTSD EWIVTRTGIR ERHIAAPNET VSTMGFEAAT
     RAIEMAGIEK DQIGLIVVAT TSATHAFPSA ACQIQSMLGI KGCPAFDVAA ACAGFTYALS
     VADQYVKSGA VKYALVVGSD VLARTCDPTD RGTIIIFGDG AGAAVLAASE EPGIISTHLH
     ADGSYGELLT LPNADRVNPE NSIHLTMAGN EVFKVAVTEL AHIVDETLAA NNLDRSQLDW
     LVPHQANLRI ISATAKKLGM SMDNVVVTLD RHGNTSAASV PCALDEAVRD GRIKPGQLVL
     LEAFGGGFTW GSALVRF
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025